TY  - CONF

T1  - The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma.

JO  - CLINICAL CANCER RESEARCH

PY  - 2003/01/01

AU  - Esser N

AU  - Konerding MA

AU  - Wolloscheck T

AU  - Wedge SR

AU  - Ryan AJ

AU  - Ogilvie DJ

AU  - Marine D

AU  - Drevs J

ED  - 

VL  - 9

IS  - 16

SP  - 6150S

EP  - 6150S

Y2  - 2024/10/23

ER  -